Current understanding of the mechanism of action of the antiepileptic drug lacosamide
- 1 February 2015
- journal article
- review article
- Published by Elsevier in Epilepsy Research
- Vol. 110, 189-205
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Neurological Disorders and Stroke (NS079202)
This publication has 135 references indexed in Scilit:
- Crystal structure of a voltage-gated sodium channel in two potentially inactivated statesNature, 2012
- Prevention of posttraumatic axon sprouting by blocking collapsin response mediator protein 2-mediated neurite outgrowth and tubulin polymerizationNeuroscience, 2012
- Identification of a Lacosamide Binding Protein Using an Affinity Bait and Chemical Reporter Strategy: 14-3-3 ζJournal of the American Chemical Society, 2011
- Suppression of inflammatory and neuropathic pain by uncoupling CRMP-2 from the presynaptic Ca2+ channel complexNature Medicine, 2011
- The acute and chronic effects of the novel anticonvulsant lacosamide in an experimental model of status epilepticusEpilepsy Research, 2011
- Development and Characterization of Novel Derivatives of the Antiepileptic Drug Lacosamide That Exhibit Far Greater Enhancement in Slow Inactivation of Voltage-Gated Sodium ChannelsACS Chemical Neuroscience, 2010
- In Silico Docking and Electrophysiological Characterization of Lacosamide Binding Sites on Collapsin Response Mediator Protein-2 Identifies a Pocket Important in Modulating Sodium Channel Slow InactivationJournal of Biological Chemistry, 2010
- Molecular Targets for Antiepileptic Drug DevelopmentNeurotherapeutics, 2007
- A pharmacophore derived phenytoin analogue with increased affinity for slow inactivated sodium channels exhibits a desired anticonvulsant profileNeuropharmacology, 2006
- Effect of systemic and intracortical administration of phenytoin in two genetic models of absence epilepsyBritish Journal of Pharmacology, 2006